Related Experiment Video
Updated: May 13, 2026

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment
Published on: June 28, 2018
Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations
Mitsuo Sato1, Jill E Larsen, Woochang Lee
1Hamon Center for Therapeutic Oncology Research, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas 75390, USA.
This study developed a human bronchial epithelial cell model to investigate lung cancer development. The model successfully replicated malignant transformation, revealing key genetic and environmental factors influencing tumor progression and patient outcomes.
Area of Science:
- * Cell Biology
- * Oncology
- * Molecular Biology
Background:
- * Understanding lung cancer pathogenesis requires robust cellular models that recapitulate key genetic alterations and cellular transformations.
- * Normal human bronchial epithelial cells (HBECs) provide a relevant starting point for modeling lung cancer, but require specific genetic modifications to achieve full malignancy.
Purpose of the Study:
- * To establish and characterize a novel HBEC-based model for studying lung cancer initiation and progression.
- * To investigate the sufficiency of specific oncogenic alterations (CDK4, hTERT, p53, KRAS, MYC) in driving malignant transformation.
- * To explore the impact of genetic variability and environmental factors on tumor development and patient prognostics.
Main Methods:
- * Utilized CDK4/hTERT-immortalized normal human bronchial epithelial cells (HBECs).
- * Introduced combinations of oncogenic alterations: p53 (sh-p53), KRAS (KRAS(V12)), and MYC (c-MYC).
- * Analyzed stepwise cellular transformation, tumor growth, histology, differentiation, and gene expression signatures.
Main Results:
- * A combination of five genetic alterations (CDK4, hTERT, sh-p53, KRAS(V12), c-MYC) was sufficient for HBEC malignant transformation.
- * Genetically identical clones showed significant variations in tumor behavior, and individual HBEC sensitivity to transformation differed.
- * High KRAS(V12) and loss of p53 were critical for transformation, while c-MYC enhanced malignancy in a specific genetic context. Serum exposure altered tumorigenicity and induced epithelial-to-mesenchymal transition (EMT).
- * An mRNA signature from this model predicted patient outcomes and response to chemotherapy.
Conclusions:
- * The developed HBEC model effectively mimics lung cancer pathogenesis, allowing study of oncogenic mutations, expression levels, and environmental influences.
- * The model demonstrates the heterogeneity of tumor development and provides insights into the roles of specific genetic alterations and cellular senescence.
- * This system offers clinically translatable applications, including the development of prognostic signatures and prediction of drug responses in lung cancer patients.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Abnormal Proliferation
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer
